- Home
- / TG Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
TG Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$25.7
2024-10-29
Market Capitalization
$4 B
2024-10-29
Revenue
$616.3 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19.0K | 152.4K | 152.4K | 152.4K | 152.4K | 152.4K | 152.0K | 152.0K | 152.0K | 6.7M | 2.8M | 233.7M | 616.3M | |
| Cost of goods sold | 14.1M | 100.7M | ||||||||||||
| Gross profit | 219.5M | 515.6M | ||||||||||||
| Gross profit margin, % | 94.0% | 83.7% | ||||||||||||
| General and administrative expense | 554.7K | 4.8M | 16.3M | 15.2M | 15.0M | 107.9M | 128.1M | 70.0M | 122.7M | 232.0M | ||||
| Operating expense total | 882.0K | 25.8M | 13.7M | 40.1M | 47.7M | 69.2M | 118.9M | 174.6M | 169.2M | 273.7M | 195.4M | 198.9M | 392.2M | |
| Depreciation and amortization | 100.0K | |||||||||||||
| EBIT | (882.0K) | (26.9M) | (23.0M) | (55.7M) | (63.2M) | (79.0M) | (118.7M) | (174.4M) | (169.1M) | (273.6M) | (344.8M) | (192.8M) | 20.6M | 123.3M |
| EBIT margin, % | -141196.4% | -15071.4% | -36567.0% | -41461.9% | -51823.5% | -77904.6% | -114736.8% | -111220.4% | -179996.1% | -6924.2% | 8.8% | 20.0% | ||
| Investment income | 15.8K | |||||||||||||
| Interest income | 30.8K | 55.0K | 174.7K | 323.0K | ||||||||||
| Interest expense | 7.1K | 905.7K | 952.9K | 930.7K | 972.7K | 5.3M | 6.3M | 5.6M | 10.2M | 12.6M | ||||
| Pre tax profit | (25.9M) | (118.5M) | (173.5M) | (172.9M) | (279.4M) | (348.1M) | (198.3M) | 13.1M | 107.4M | |||||
| Income tax expense | 330.0K | 390.0K | (339.8M) | |||||||||||
| Net Income | (853.1K) | (18.1M) | (20.5M) | (55.8M) | (62.9M) | (78.3M) | (118.5M) | (173.5M) | (172.9M) | (279.4M) | (348.1M) | (198.3M) | 12.7M | 447.2M |
| EPS | (1.5) | 0.1 | 2.8 |